You are here

  • Home
  • Archive
  • Volume 62, Issue 4
  • A combined oncogenic pathway signature of BRAF, KRAS and PI3KCA mutation improves colorectal cancer classification and cetuximab treatment prediction

Citation Tools

Article menu
XML
Colon
Original article
A combined oncogenic pathway signature of BRAF, KRAS and PI3KCA mutation improves colorectal cancer classification and cetuximab treatment prediction

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Tian S, Simon I, Moreno V, et al
A combined oncogenic pathway signature of BRAF, KRAS and PI3KCA mutation improves colorectal cancer classification and cetuximab treatment prediction
Gut 2013;62:540-549.